← All stocks

Johnson & Johnson

JNJ Net selling

CIK 0000200406 #269 in the set updated 17 Sep 2026

Bought (12 mo)

$257.69K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$154.85M

$0.00 on a plan · $118.38M straight out of an exercise

Sold at will

$36.47M

6 of 29 sales

Net

−$154.60M

−$36.21M against sales at will

By person

13 insiders · 34 transactions

52.6×

J. Duato holds 52.6 times base salary in stock. $84.30M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what J. Duato last reported holding, valued at $274.74, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Duato Joaquin

CEO and Chairman of the Board

—

$66.84M (6)

−$66.84M

306,819

0.0127%

$84.30M

−15.5%

Wolk Joseph J

Exec VP, CFO

—

$21.77M (4) scheduled

−$21.77M

82,835

0.0034%

$22.76M

+20.3%

REED JOHN C

EVP, Innovative Medicine, R&D

—

$17.29M (4) scheduled

−$17.29M

24,911

0.0010%

$6.84M

+70.9%

Swanson James D.

EVP, CIO

—

$15.11M (3) scheduled

−$15.11M

25,698

0.0011%

$7.06M

+76.3%

Schmid Timothy

EVP, WW Chair, MedTech

—

$15.08M (5) scheduled

−$15.08M

26,251

0.0011%

$7.21M

+89.6%

Broadhurst Vanessa

EVP, Global Corp Affairs

—

$7.30M (2) scheduled

−$7.30M

23,003

0.0010%

$6.32M

+16.0%

Forminard Elizabeth

EVP, Chief Legal Officer

—

$4.09M (2) scheduled

−$4.09M

16,994

0.0007%

$4.67M

+103.8%

Taubert Jennifer L

EVP, WWC. Innovative Medicine

—

$3.95M (1) scheduled

−$3.95M

194,451

0.0081%

$53.42M

+25.6%

Wengel Kathryn E

EVP, Chief TO and Risk Officer

—

$2.41M (1) scheduled

−$2.41M

114,288

0.0047%

$31.40M

+38.9%

Decker Robert J

VP Corporate Controller

—

$1.01M (1) scheduled

−$1.01M

23,682

0.0010%

$6.51M

+24.8%

MORIKIS JOHN G

Director

$257.69K (1)

—

+$257.69K

1,849

<0.0001%

$507.86K

+208.9%

Mulholland Kristen

EVP, Chief HR Officer

—

19,830

0.0008%

$5.45M

+69.6%

WEINBERGER MARK A

Director

—

1,000

<0.0001%

$274.74K

—

Johnson & Johnson

By person

Individual transactions

What was left out